Skip to main content
. 2015 Jul 20;33(31):3544–3549. doi: 10.1200/JCO.2015.61.4503

Table 1.

Patient Demographics and Clinicopathologic Characteristics

Characteristic No. (%) of Patients
P (hereditary v nonhereditary)*
With Hereditary Syndrome (n = 67) Without Hereditary Syndrome (n = 126) Total (N = 193)
Mean (range) age at diagnosis, years 28.8 (17-35) 29.1 (12-35) 29 (12-35) NS
Female sex 33 (49.2) 68 (54.0) 101 (52.3) NS
Race/ethnicity NS
    White 51 (76.1) 94 (74.6) 145 (75.1)
    Black 5 (7.5) 9 (7.1) 14 (7.3)
    Hispanic 8 (11.9) 18 (14.3) 26 (13.5)
    Asian 3 (4.5) 5 (4.0) 8 (4.1)
Colorectal cancer site < .001
    Right colon 15 (22.4) 25 (19.8) 40 (20.7)
    Left colon 12 (17.9) 46 (36.5) 58 (30.0)
    Rectum 29 (43.3) 54 (42.9) 83 (43.0)
    Not specified 11 (16.4) 1(0.8) 12 (6.2)
Tumor stage < .001
    0/Tis 1 (1.5) 1 (0.8) 2 (1.0)
    I 8 (11.9) 7 (5.6) 15 (7.8)
    II 11 (16.4) 8 (6.3) 19 (9.8)
    III 20 (29.9) 38 (30.2) 58 (30.1)
    IV 19 (28.4) 71 (56.3) 90 (46.6)
    Unknown 8 (11.9) 1 (0.8) 9 (4.7)
Grade of differentiation < .001
    Moderately differentiated 45 (67.2) 84 (66.7) 129 (66.8)
    Poorly differentiated 8 (11.9) 39 (31.0) 47 (24.4)
    Unknown 14 (20.9) 3 (2.4) 17 (10.4)
Signet ring cells < .001
    Yes 3 (4.5) 18 (14.3) 21 (10.9)
    No 50 (74.6) 108 (85.7) 158 (81.9)
    Unknown 14 (20.9) 0 (0) 14 (7.2)
Met Amsterdam I/II criteria 11 (16.4) 1 (0.8) 12 (6.2)
Family history < .001
    FDR with CRC 19 (28.4) 4 (3.2) 23 (11.9) < .001
    FDR with other cancer 20 (29.9) 30 (23.8) 50 (25.9) NS
    SDR with CRC 28 (41.8) 33 (26.2) 62 (32.1) < .047
    SDR with other cancer 35 (52.2) 95 (75.4) 130 (67.4) .001
Personal history of other cancer 22 (32.8) 13 (10.3) 35 (18.1) < .001

Abbreviations: CRC, colorectal cancer; FDR, first-degree relative; NS, not significant; SDR, second-degree relative.

*

All tests were two sided.

HHS Vulnerability Disclosure